The analyst rating for XTALPI (02228.HK) is a "Buy" based on several key factors highlighted in the Cinda Securities research report. The company is recognized as a leader in the cutting-edge technology segment, particularly in robotics and AI pharmaceuticals, which reflects its dual innovation concepts. From a medium-to-long-term perspective, XTALPI's advanced industrial model is expected to drive technological advancements in the industry, providing significant growth potential. Cinda Securities forecasts substantial increases in operating revenue over the next few years, with projected revenues of RMB781 million, RMB1.093 billion, and RMB1.496 billion for 2025-2027, representing year-on-year growth of 193%, 40%, and 37%, respectively. Additionally, the forecast includes a turnaround in net profits, moving from losses to a profit of RMB100 million by 2027. These factors collectively support the positive rating.

Valuation Metrics

The current forward P/E ratio for (02228.HK) is -328.62, compared to its 5-year average forward P/E of -74.87. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-74.87

Current PE

-328.62

Overvalued PE

-9.03

Undervalued PE

-140.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-64.10

Current EV/EBITDA

-104.39

Overvalued EV/EBITDA

-32.99

Undervalued EV/EBITDA

-95.21

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

59.26

Current PS

59.42

Overvalued PS

77.22

Undervalued PS

41.30

Financials

AI Analysis

Annual

Quarterly

Whales Holding 02228

Trading Trends

People Also Watch

Frequently Asked Questions

What is (02228) stock price today?

The current price of 02228 is 9.57 USD — it has increased 0.31

What is (02228)'s business?

What is the price predicton of 02228 Stock?

Wall Street analysts forecast 02228 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 02228 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (02228)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (02228)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (02228). have?

(02228) has 0 emplpoyees as of March 04 2026.

What is (02228) market cap?

Today 02228 has the market capitalization of 0.00 USD.

02228 Overview